Meet the EUCROF27 Programme Committee
EUCROF is delighted to introduce the minds that are carefully curating this year’s programme. With combined expertise that spans across Europe and from each corner of the Clinical Research landscape, the EUCROF27 Programme Committee will construct the conference’s agenda to portray a perfect snapshot of the current state of European Clinical Research, as well as discussing critical issues arsing in the sector.
With breakout streams that covered AI, DCTs, Regulatory Considerations, Paediatrics, Medical Devices, and more, EUCROF26’s Programme captured key ideas in clinical research in 2026. In 2027, the presentations promise updated, cutting-edge ideas on topics that are paramount to our industry, with two focused streams: regulatory & clinical operations.
Meet the people putting in the work to showcase innovation at EUCROF27.
Programme Committee Co-Chairs
Mirjam Huigen, IQVIA
Mirjam began her career in clinical research 21 years ago at Quintiles (now IQVIA), one of the world’s leading contract research organizations. Over the years, she has held a variety of roles within IQVIA, ranging from clinical monitoring to managing diverse CRA teams—including in-house, customer-dedicated, and Nordic-region CRAs. Her deep operational expertise and leadership skills led her to the role of Clinical Lead.
For the past five years, Mirjam has served as a Clinical Lead Line Manager, overseeing the clinical delivery of global projects in gastroenterology, immunology, and women’s health. In this role, she ensures that clinical trials are executed in alignment with sponsor expectations, project scope, and the highest quality standards. Her strategic oversight and commitment to excellence have made her a key contributor to the success of complex, multinational clinical programs.
Marcello Milano, BioMarin
Marcello Milano is a director in the R&D and Regulatory Policy team at BioMarin, a global biotechnology company that develops innovative therapies for rare genetic diseases. In his role, Marcello focuses on EU regulatory intelligence, regulatory policy development and advocacy as a member of working groups across industry organizations, including EuropaBio, EUCOPE, MPP and BIA. Amongst other roles, he acts as EUCOPE alternate in the Accelerating Clinical Trials in Europe (ACT-EU) Multistakeholder Platform Advisory Group.
Marcello has been part of the biopharmaceutical industry for over 30 years, of which 20 in the regulatory affairs field, with previous roles in Chiesi and GSK. He holds a chemistry degree from the University of Padua, It
Programme Committee
Antoinette van Dijk
Doris Neuhauser
Martin O'Kane
Peter Casteleyn
Register for EUCROF27 Conference Updates
Keep up with announcements for EUCROF27 Conference.